- $420.02m
- $857.31m
- $457.43m
- 54
- 68
- 66
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 58.5 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.03 | ||
| Price to Tang. Book | 12.72 | ||
| Price to Free Cashflow | 17.03 | ||
| Price to Sales | 0.92 | ||
| EV to EBITDA | 240.28 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3% | ||
| Return on Equity | -9.6% | ||
| Operating Margin | -6.76% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,055.5 | 912.4 | 472.31 | 463.29 | 457.43 | 454.05 | 459 | -16.08% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +497.14 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 30th, 2021
- Public Since
- February 14th, 2022
- No. of Shareholders
- 10,900
- No. of Employees
- 2,600
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 27,220,942
- Address
- 10225 Westmoor Drive, WESTMINSTER, 80021
- Web
- https://www.zimvie.com/en
- Phone
- +1 3034437500
- Contact
- Marissa Bych
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for ZIMV
ZimVie Inc Annual Shareholders Meeting
Q2 2024 ZimVie Inc Earnings Release
Similar to ZIMV
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Zimvie share price?
As of Today at 19:25 UTC, shares in Zimvie are trading at $15.43. This share price information is delayed by 15 minutes.
How has the Zimvie share price performed this year?
Shares in Zimvie last closed at $15.43 and the price had moved by +87.94% over the past 365 days. In terms of relative price strength the Zimvie share price has outperformed the S&P500 Index by +56.4% over the past year.
What are the analyst and broker recommendations for Zimvie?
The overall consensus recommendation for Zimvie is Sell. You can view the full broker recommendation list by unlocking its StockReport.
What is the Zimvie dividend yield?
Zimvie does not currently pay a dividend.
Does Zimvie pay a dividend?
Zimvie does not currently pay a dividend.
When does Zimvie next pay dividends?
Zimvie does not currently pay a dividend.
How do I buy Zimvie shares?
To buy shares in Zimvie you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zimvie?
As of the previous close price of $15.43, shares in Zimvie had a market capitalisation of $420.02m.
Where are Zimvie shares listed?
Here are the trading details for Zimvie:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ZIMV
What kind of share is Zimvie?
Based on an overall assessment of its quality, value and momentum Zimvie is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zimvie share price forecast for 2024?
The analyst consensus target price for shares in Zimvie is $16.00. That is 3.69% above the last closing price of $15.43.
Analysts covering Zimvie currently have a consensus Earnings Per Share (EPS) forecast of $0.11 for the next financial year.
What is the trend in the Zimvie share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zimvie. Over the past six months, its share price has outperformed the S&P500 Index by +72.59%.
As of the last closing price of $15.43, shares in Zimvie were trading +15.29% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zimvie PE Ratio?
The Zimvie PE ratio based on its reported earnings over the past 12 months is 58.5. The shares last closed at $15.43.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zimvie?
We do not have data on Zimvie's directors